ArticleMicroorganisms2025
MACNeXt-Based Bacteria Species Detection.
Article in Microorganisms, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bacteria underpin human health, environmental balance, and industrial processes. Rapid and accurate identification is essential for diagnosis and responsible antibiotic use. Culture, biochemical tests, and microscopy are slow, expensive, and depend on expert judgment, which introduces subjectivity and errors. This research aims to recommend a new generation deep learning architecture for bacterial species classification. We curated a bacterial image dataset, and this dataset contains 18,221 microscopic images from 24 species under standard laboratory conditions. All images passed clarity and focus checks. We developed a compact CNN, the Multiple Activation Network (MACNeXt). The recommended MACNeXt preserves local feature extraction and improves representation with two activation functions (GELU and ReLU) and a multi-branch design. The aim is high accuracy with low computational cost for routine clinical use. MACNeXt achieved 90.97% accuracy, 89.63% precision, 88.64% recall, and 88.99% F1-score on the test set. The calculated results and findings showcase balanced and stable performance across species with an efficient, lightweight design since the introduced MACNeXt has about 4.4 million learnable parameters. The results of the MACNeXt openly demonstrate that this CNN is a compact, lightweight, and highly accurate CNN model.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.